endrainc.com (NDRA): Prakiraan wutah bathi resik saben saham kanggo taun ngarep

Simbol lan logo merek ENDRA Life Sciences Inc (NDRA)

The forward net income growth rate for ENDRA Life Sciences (NDRA) has reached a value where the parameter mark equals 0.00. This trend is supported by the development of the TAEUS system, an affordable MRI analogue for diagnosing liver steatosis. The business relies on scalable software and sensors, eliminating the need for manufacturing plant expenditures. ENDRA Life Sciences (NDRA) is currently revising clinical protocols to bring the equipment into compliance with US regulatory standards.

NDRA: Prakiraan wutah bathi resik saben saham ing taun ngarep ENDRA 04.07.2022 - 15.11.2026

Rincian analitis perusahaan ENDRA Life Sciences Inc (NDRA)

- rega saham lan konsensus proyeksi valuasi:
Pambiji fundamental perusahaan:ENDRA Corp, NDRA
Produk dadi ENDRA Life Sciences Inc.

This indicator assesses the expected earnings per share (EPS) dynamics for the coming year by measuring the gap between current performance and analyst consensus forecasts. By analyzing the trend of EPS growth projections, an investor can gauge the probability of commercial success for ENDRA Life Sciences (NDRA), which currently depends not on general economic conditions, but on obtaining insurance reimbursement codes for TAEUS systems.